YH25448, a 3rd Generation EGFR-TKI, in Patients with EGFR-TKI-resistant NSCLC: Phase I/II Study Results
July 22, 2026
YH25448, a 3rd Generation EGFR-TKI, in Patients with EGFR-TKI-resistant NSCLC: Phase I/II Study Results
By: Oscotec 포토옹
COMPANY
SCIENCE
INVESTORS
Sustainability
CONTACT